Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
No more mail: PostNord to stop delivering letters to Denmark at the end of 2025
PostNord will stop delivering letters to the Nordic nation at the end of 2025, though package distribution will remain.
The Times and Democrat3dOpinion
America can save trillions on Medicaid | Martin Hoyt
The American people voted for government reform in November, and we have seen actions taken by President Donald Trump aiming ...
Jacobin on MSN4d
You’ve Already Paid for Overpriced Weight-Loss Drugs
US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...